Emy Chen, PhD
Senior Director of Licensing
Emy Chen, PhD, is the new Senior Director of Licensing at the Robert and Renée Belfer Office for Dana-Farber Innovations (BODFI). In this role, she has oversight over the Innovations Licensing team as a whole. A primary focus for her will be to further
refine and optimize the team's ability to provide excellent partnership and collaboration both with clinicians and research scientists at Dana-Farber and with external stakeholders in industry. Prior to joining BODFI, Emy was most recently a Director
of Licensing at Partners HealthCare Innovation, where she spent 13 years supporting investigators and building relationships with biotech and pharma companies, primarily for innovators in the disciplines of Medicine, Neuroscience and Dermatology.
Emy holds a PhD from Harvard University in Molecular and Cellular Biology, a BA from University of California, Berkeley in Molecular and Cell Biology, and is a registered patent agent with the United States Patent and Trademark Office (USPTO).
Nichole Straub is the Administrative Director at BODFI. Nichole oversees finance and compliance in the Innovations office, while taking a stance on operational efficiencies for all of the teams. Nichole comes to the Innovations team with a wide breadth
of experience within Dana-Farber. She has supported grants management, strategic centers, and research administration, and interfaces within clinical and research programs. She has a strong interest in data management when it comes to patient derived
samples and the ever-changing regulatory front. Nichole holds a BS in Economics from Purdue University.
Kate Strayer-Benton, MBA
Senior Director of Business Development
As Senior Director of Business Development, Kate Strayer-Benton's goal is to accelerate the time it takes for breakthrough science to get to patients – working with investigators and companies to identify new opportunities for collaboration; building
a robust BD pipeline; and developing and driving the BD process. Kate was formerly Director of Strategy and Corporate Development at Momenta Pharmaceuticals. Prior to Momenta, she spent a decade at Health Advances as a strategy consultant, working
with health care leaders to bridge technical and business objectives and advance medical innovations with the greatest impact on patient lives. Kate received her MBA from the Tuck School of Business at Dartmouth, where she focused on healthcare, strategy,
and innovation; she has a BA in Psychology/Neuroscience from Dartmouth College.
Licensing Team 1
Raymond Walsh, JD
Associate Director, Licensing, Team 1
Ray Walsh, JD, is the Team 1 Lead at BODFI. He received his Bachelor of Arts in Biology from Wesleyan University in Middletown CT, both his Master of Science and Master of Business Administration at the University of Rhode Island in Kingston, RI and his
Juris Doctor degree from New England School of Law in Boston, MA. He is a member of the Massachusetts and Connecticut State bar associations and is registered to practice before the United States Patent and Trademark Office, with a scientific specialization
in biotechnology. Prior to his position at BODFI, Ray spent 14 years as a research scientist working in government, academic, and industry laboratories. After finishing law school, he worked in the Greater Boston area managing the intellectual property
portfolios for a variety of for-profit and non-profit organizations, including start-ups, large and small companies, and advising a non-profit sponsor of academic research. Ray also worked in technology transfer at the University of Rhode Island,
the National Cancer Institute (NIH), and Walter Reed Army Institute of Research. He is a member of many professional organizations, including the Association of University Technology Managers (AUTM) and the Licensing Executive Society, USA and Canada
Micah Belew, PhD
Micah Belew, PhD, assists BODFI's Team 3 by analyzing invention disclosures for IP strategy and IP portfolio for the marketing of commercially valuable assets. Additionally, Micah reviews collaborative research agreements and manages multiple licensing
agreements. Micah received his PhD from the University of Massachusetts Medical School, studying the genetics of axon regeneration, aging, and metabolism; he received his MS from the University of California, Davis, studying the molecular muscle physiology
of exercise adaptation.
Jodi Hecht, PhD
Senior Licensing Manager and Market Strategist
Jodi Hecht, PhD, joined BODFI in 2017. She negotiates transactions between industry and Dana-Farber to support research activities, and she manages the intellectual property portfolio for multiple principal investigators at Dana-Farber. She is also an
alliance manager for several alliances between Dana-Farber and industry.
Prior to joining BODFI, Jodi worked as a Licensing Associate in the Technology Ventures office at Beth Israel Deaconess Medical Center. Jodi received a PhD in Molecular Biology from Boston University, and an MSc in Biology and Vision Science and a BSc
in Biochemistry from the University of Waterloo.
Lisa Lin, PhD
Licensing Manager and Market Strategist
Lisa Lin, PhD, is currently a licensing manager and market strategist for Team 1. She joined BODFI in February 2020. She is responsible for negotiating agreements for, and managing inventions from, researchers in the departments supported by Team 1. Before
joining BODFI, Lisa worked as the licensing manager for the College of Medicine at the University of Arizona for four years. Her technology transfer career started as an intern at Emory University technology transfer office. Lisa gained her PhD in
immunology from Duke University in North Carolina.
Jing Zhang, PhD
Senior Licensing Manager and Market Strategist
Jing Zhang, PhD, joined BODFI as a Technology Transfer Specialist in 2014. She is responsible for negotiating agreements, as well as monitoring financial post-agreement compliance.
Prior to joining BODFI, Jing worked in the Fellows Program at Harvard University's Office of Technology Development to conduct early commercialization assessment of inventions. Jing received her BS in Biological Science from the University of Science
and Technology of China, and earned her PhD in Chemical Biology from Harvard University. She conducted her graduate and postdoctoral research on oncogenic kinase signaling at Dana-Farber.
Licensing Team 2
Janet Ralbovsky, PhD
Associate Director, Licensing, Team 2
Janet Ralbovsky, PhD, is currently the Innovation and Licensing Lead, Team 2 in BODFI, and manages chemistry-related Dana-Farber technologies. Previously, she was a Licensing Associate at the University of Tennessee Research Foundation (UTRF), where she
was responsible for the commercialization of a broad portfolio of intellectual property developed at the University of Tennessee Health Science Center. Prior to joining UTRF, Janet worked in drug discovery as a medicinal chemist and project leader
at Johnson & Johnson and Cara Therapeutics, Inc. Janet holds a PhD in Organic Chemistry from the Pennsylvania State University, a MS from the University of Rochester, and a BA from Smith College. She is a registered patent agent with the United States
Patent and Trademark Office (USPTO).
Jill Edgar, PhD
Senior Licensing Manager and Market Strategist
Senior Licensing Manager and Market Strategist
Jill Edgar, PhD, joined BODFI in 2020, and is a member of Licensing Team 2, which is responsible for managing and commercializing inventions arising from chemistry-related Dana-Farber technologies. She has over 10 years of substantial scientific, tech
transfer and patent experience. Prior to BODFI, Jill served as a Senior Licensing Associate at Boston College, and prior to that as a Licensing Associate at Tufts University. She also worked as a Patent Agent in the biotechnology area of the law offices
at Nixon Peabody LLP and most recently, Morse. Jill received her undergraduate degree in Biology and PhD in Biomedical Science from Brown University, then completed a post-doctoral fellowship in Matrix Biology at the Karolinska Institute in Stockholm,
Aida Herrera, PhD
Senior Licensing Manager and Market Strategist
Aida Herrera, PhD, joined BODFI in 2019 and is a member of Team 2, which is responsible for managing and commercializing inventions arising from chemistry-related Dana-Farber technologies. Prior to joining BODFI, Aida worked for both Boston Children’s
Hospital and The Schepens Eye Research Institute/Massachusetts Eye and Ear, where she spent nine years supporting investigators across various departments, including Ophthalmology, Otolaryngology, Cardiac Surgery, Gastroenterology, and Endocrinology,
and was responsible for the commercialization of a broad range of technologies. Earlier in her career, Aida worked as a technology specialist focused on patent prosecution in the biotechnological, chemical, and mechanical arts. She holds a BS in chemistry
from the University of Chicago, a PhD in chemistry from Tufts University, and completed postdoctoral research work in both the Biological Engineering Division at MIT and the Chemistry Department at Northeastern University.
Zachary Rothman, JD
Senior Research Contracts Associate
Zack joined BODFI as a Research Contracts Associate in 2018. He is responsible for drafting, reviewing, and negotiating a variety of research agreements with corporate sponsors and collaborating institutions.
Prior to joining BODFI, Zack worked in the Clinical Trials Business Office at Boston Children's Hospital, preparing written agreements with both for-profit and non-profit organizations for the purposes of conducting and furthering clinical research. Zack
earned a JD with a concentration in Health Law from the Boston University School of Law, and a BS from Florida State University.
Renatus Sinkeldam, PhD
Renatus Sinkeldam, PhD, conducted his undergraduate research (BSc and MSc) in inorganic and organic chemistry labs at the University of Amsterdam, The Netherlands, where he worked on small molecule synthesis and their characterization. He obtained his
PhD from Eindhoven University of Technology, The Netherlands, completing his doctoral thesis in the areas of macro- and supra-molecular chemistry. As a postdoctoral fellow and later a project scientist at the University of California, San Diego, Renatus
designed and synthesized non-perturbing fluorescent nucleosides for the study of nucleic acid structure, stability, lesions, and interactions with small molecules. After his move to St. Louis, he joined the Biotechnology and Life Science Advising
Group (BALSA) for exposure to the possibilities of a career away from the bench. While at BALSA, he obtained consultancy experience working on short projects in small diverse teams. This led to a marketing internship, and later, a tech transfer trainee
position at the Office for Technology Management at Washington University in St. Louis. The latter was quickly followed by a position as Licensing Associate, where he managed a diverse technology portfolio. In 2018, Renatus joined BODFI as a Licensing
Associate. He enjoys the exposure to new and exciting Dana-Farber technologies and assisting Dana-Farber investigators with all facets of technology commercialization.
Nicholas Corsaro, JD
Director, Research Contracts
Nicholas Corsaro, JD, joined BODFI as Assistant Director, Innovation Contracts, in October 2020. He leads the Contracts Team, which drafts, reviews, and negotiates a variety of academic and corporate research agreements among industry sponsors, universities,
and other collaborating institutions.
Prior to joining BODFI, Nicholas worked as the Manager of Grants and Contracts in the Research Administration office of Tufts Medical Center, and as a Senior Agreement Associate in the Research Management office of Partners Healthcare, where he drafted,
reviewed, and negotiated a variety of academic and corporate-sponsored research agreements. Nicholas earned his JD from Suffolk University Law School, where he was a member of the Suffolk University Law Review.
Quintin Schwab joined BODFI as a Research Contracts Specialist in June 2020. He is responsible for the drafting, reviewing, and negotiation of a variety of academic and corporate research agreements among industry sponsors, universities, and other collaborating
Prior to joining BODFI, Quintin served for over five years as the Material Transfer Agreement (MTA) Coordinator at the Center for Technology Licensing at Cornell University, where he was responsible for processing and negotiating several hundred outbound
MTAs annually for Cornell campuses across the world. He also worked on Inter-Institutional Agreements (IIAs), bailment licenses, and a variety of compliance and due diligence projects.
Quintin graduated with a BA in psychology from Cornell, where he studied Mandarin Chinese and worked as an assistant editor of the Cornell Daily Sun newspaper.
Hussain Tariq, JD
Research Contracts Specialist
Hussain Tariq, JD, joined BODFI as a Research Contracts Specialist in November 2020. He is responsible for the drafting, reviewing, and negotiation of a variety of academic and corporate research agreements among industry sponsors, universities, and other collaborating institutions. Prior to joining BODFI, Hussain held various legal internships, including in Dana-Farber’s Office of General Counsel and in the Massachusetts Attorney General’s Office Healthcare Division. Hussain obtained his BA in Political Science from Xavier University and his JD from Northeastern University School of Law, where he had a concentration in Health Law.
Yihua (Elly) Xu
Elly Xu joined BODFI as a Research Contracts Specialist in June 2020. She is responsible for the drafting, reviewing, and negotiation of a variety of academic research agreements among industry companies, institutions, and universities.
Prior to joining BODFI, Elly had been working in the legal industry for over six years, especially focusing on contract affairs. She worked as a Legal Specialist in Prysmian Group, where she drafted, reviewed, and negotiated a variety of commercial agreements
and confidentiality agreements for all five subsidiary companies. Elly received her degree in law from Soochow University.
Finance and Operations
Senior Finance and Operations Manager
Kathy Copson joined BODFI in 2015 as the Financial Systems Specialist. She has extensive experience as a revenue manager in the facilities services, software, and media licensing industries, with a focus on financial business process improvement and enhanced
systems utilization. Her roles have included being a core member of an Enterprise Resource Planning system upgrade team and subsequently, a trainer for ERP Financials. Kathy has a BA from Boston University.
Senior Technology Transfer Accountant
Christopher Almada joined Dana-Farber in 2019 as a Senior Technology Transfer Accountant. He is responsible for the processing of transactions relating to licensing, patents, and royalty distributions. Prior to joining Dana-Farber, Chris worked at UMass
Medical School and BNY Mellon Asset Servicing, where he handled financial statement preparation relating to assets, liabilities, revenue, and expenses, along with applicable footnotes and other disclosures. In addition, he prepared reconciliations
while noting any exceptions and providing necessary support; assisted with the month-end close process; and executed tax reporting per 501(c)(3) requirements. Chris has participated in multiple system conversions in which he spearheaded the automation
of monthly, semi-annual, and annual reporting, building the process from the ground up, including testing, feedback, and implementation.
Linda Baldwin, JD, MBA
Linda Baldwin joined BODFI in 2018. Assisting Brendan Mahoney, Linda performs intellectual property compliance reporting to federal and foundation sponsors for Dana-Farber's inventions and patents. Linda received an MBA from Northeastern University and
a JD degree from New England Law-Boston.
Previously, Linda worked as a litigation support specialist on various legal cases, including an IP non-joinder action to correct inventorship, and as a staff attorney for the Commonwealth of Massachusetts.
Peter Hodges, PhD
Senior Agreement Associate
Peter joined Dana-Farber’s BODFI in 2012 and manages IP from multiple departments.
After teaching at several Boston-area colleges, Peter joined Proteome, Inc., a start-up bioinformatics company. Following the acquisition of Proteome by Incyte Corporation, Peter moved to business development, and was involved in out-licensing Incyte's
vast patent portfolio. Peter transitioned to technology transfer at Boston Children's Hospital in 2004, and handled a wide range of technologies, including research tools, bioinformatics and software, genetics, genomics and proteomics, cardiology,
oncology, and stem cell technologies.
Peter received his PhD in Human Genetics from Yale University School of Medicine; he did post-doctoral work in RNA biology at the Clinical Research Centre, Harrow, UK, and at the University of Edinburgh.
Ashley Lezama, joined the team in 2020 as the Program Administrator for the Dana-Farber Innovations office. She is responsible for providing administrative support and calendar management to the Administrative, Licensing and Business Development Directors.
In her role, Ashley also provides a variety of general office supports for the Innovations team.
Prior to joining BODFI, Ashley worked at Boston Children's Hospital as an Administrative Assistant to the Director of Nursing Diversity Initiatives, and more recently as an Assistant Property Manager providing parallel administrative support. Ashley received
her BA from Northeastern University.
Business and Compliance Analyst
Brendan Mahoney joined BODFI in June 2014, maintaining Dana-Farber's invention and intellectual property reporting obligations to federal research sponsors in accordance with the Bayh-Dole Act. Brendan creates initial Dana-Farber invention disclosure
records and completes invention and intellectual property statements for National Institutes of Health awards' Research Performance Progress Reports. Brendan also assists BODFI in data management, maintenance, and reporting for intellectual property
Ali Mbaye, MS
Senior Technology Transfer Accountant
Ali Mbaye joined Dana-Farber in 2018 as a Senior Technology Transfer Accountant. He is responsible for the review and approval of all Sponsored Research Agreement (SRA) budgets; maintenance of the financial records in the database; and submittal of the
awards to Dana-Farber Research Accounting. He works closely with the Institute's departmental grant managers and licensing staff to monitor SRA financial obligations.
Prior to joining BODFI, Ali worked at Youthbuild USA as a Financial Grants Manager, providing monthly financial reports and forecasting, reviewing and approving budgets, preparing and completing drawdowns, and closing both federal and private awards.
Ali earned a Masters degree in Economics from Suffolk University and a Masters degree in Industrial Organization from Cheith Anta Diop University in Senegal.
Business Development and Innovation Strategy
Robert Distel, PhD
Technology and Business Development Manager
Robert Distel, PhD, joined BODFI in 2015 as a Special Advisor for Technology Development. Robert acts as a point person in the ongoing program to bring novel and innovative early-stage technologies and products – as well as collaborative opportunities
– to Dana-Farber's scientists and physicians. He also works with investigators interested in developing research tools. Prior to joining BODFI, Robert was a member of the Center for Clinical and Translational Research at Dana-Farber and director of
its Translational Research Laboratory. He was also the associate director of the Laboratory for Innovative Translational Technology at Harvard Catalyst. Robert earned his PhD in Biology from Tufts University, and completed post-doctoral training with
Bruce Spiegelman, PhD, at Dana-Farber. He maintains close ties to the research community as an active visiting member of the Novina Laboratory in the Department of Cancer Immunology and Virology.
Steven Neier, PhD
Business Development Associate and Scientific Program Manager
Steven Neier, PhD, is a Business Development Associate and Scientific Program Manager. Steven works closely with investigators, pharmaceutical companies, and venture capital groups to assist investigators in identifying new collaborations and commercializing
their technologies. Prior to joining BODFI, Steven was a Scientist I in Dr. Carl Novina's laboratory at Dana-Farber, where he influenced the scientific direction and led efforts relating to the commercialization of technologies being developed in
the lab. Steven's research focused on T cell signaling and next-generation autologous cell therapies. Steven received his BS in Mathematics from Union College and earned his PhD in Immunology from the Mayo Clinic.
Marketing and Business Development Analyst
Lily Tan joined the Dana-Farber Innovations office as the Marketing and Business Development Analyst in May 2020. Her role includes developing and executing on the marketing strategy for the internal and external Innovations audience, with the goal of
reaching out to more investigators, pharmaceutical companies, and venture capital groups in the effort to form strong alliances that will bring science from bench to clinic. Prior to joining BODFI, Lily worked at a marketing agency that strategized
for clients of various sectors, from CPG to B2B companies. Lily received her BA in Biology from Boston University.
Ramasamy Sakthivel, PhD
Director, Accelerator Program
Ramasamy (Sakthi) Sakthivel, PhD, joined the Belfer Office for Dana-Farber Innovations in 2020, and comes to this role with a decade of experience in academia and 16 years in biotech. Sakthi's accomplishments include a record of building successful startup
biotech businesses and the programs to support early-stage research and development activities. He also has a track record of securing funding through federal and state programs to support new biological and biomedical product development.
Sakthi has an extensive scientific background that includes regenerative and cell therapy, cardiovascular, hematology-oncology, and immunology, while also generating several Intellectual Property filings, identifying technologies, and creating spin-offs
based on those technologies. He has served on the senior management teams of Allosource.org, Arteriocyte, Inc., and StemMed, Inc., and has managed strategic relationships with various universities, inventors, clinical investigators, partners, and
investors. Sakthi received his PhD in Tumor Biology/Immunology from Madras University, India, and an MBA in Healthcare Management from Weatherhead School of Management at Case Western Reserve University.